Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)

China flag China · Delayed Price · Currency is CNY
9.64
-0.54 (-5.30%)
Apr 29, 2026, 3:00 PM CST
24.07%
Market Cap 8.43B
Revenue (ttm) 792.76M
Net Income (ttm) 130.57M
Shares Out 828.30M
EPS (ttm) 0.16
PE Ratio 63.63
Forward PE 32.32
Dividend 0.10 (0.98%)
Ex-Dividend Date Jul 17, 2025
Volume 17,879,241
Average Volume 11,273,066
Open 10.18
Previous Close 10.18
Day's Range 9.52 - 10.18
52-Week Range 7.70 - 12.51
Beta -0.20
RSI 42.24
Earnings Date Apr 29, 2026

About SHA:603229

Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is b... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 1,219
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603229
Full Company Profile

Financial Performance

In 2025, SHA:603229's revenue was 792.76 million, a decrease of -0.32% compared to the previous year's 795.29 million. Earnings were 130.57 million, a decrease of -36.86%.

Financial Statements

News

There is no news available yet.